Devices › Dilator, catheter, ureteral
Device brand name · Balloon dilation catheter
Bard X-Force Balloon Dilation Catheter: medical device reports filed with FDA
240 reports name it, 2017–2026. Manufacturer given most often on reports: C R Bard Covington -1018233. Product code EZN.
- 240
- device reports naming the brand
- 0% of all MAUDE reports · about 26 a year
- 22
- reports, 12 months to August 2026
- 21 in the 12 months before
- 92.5%
- classified as malfunction
- 73.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 240 reports that name the brand "Bard X-Force Balloon Dilation Catheter" (balloon dilation catheter), received between May 2017 and August 2026; the manufacturer given most often on reports is C R Bard Covington -1018233. Spellings of one product vary from report to report.
22 reports arrived in the 12 months to August 2026, close to the 21 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.5%) and injury (7.5%); across all dilator, catheter, ureteral reports (product code EZN) death is recorded in 0.5% and malfunction in 73.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are fluid/blood leak (25%), inflation problem (15.4%) and burst container or vessel (13.3%). The patient problems coded most often are no patient involvement, appropriate clinical signs, symptoms and conditions term/code not available and exposure to body fluids. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 1,112 reports carrying product code EZN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Fluid/blood leak | 60 | 25% | 6.6% |
| Inflation problem | 37 | 15.4% | 10.3% |
| Burst container or vessel | 32 | 13.3% | 14.5% |
| Material fragmentation | 29 | 12.1% | 2.8% |
| Material rupture | 23 | 9.6% | 4.9% |
| Leak/splashthe device leaked | 18 | 7.5% | 6.8% |
| Component misassembled | 17 | 7.1% | 1.5% |
| Material puncture/hole | 16 | 6.7% | 3.1% |
| Breakthe device broke | 15 | 6.3% | 4.5% |
| Device handling problem | 14 | 5.8% | 1.3% |
| Material split, cut or torn | 8 | 3.3% | 0.6% |
| Deflation problem | 7 | 2.9% | 2.6% |
| Difficult to removethe device was hard to remove | 7 | 2.9% | 1.5% |
| Pressure problem | 6 | 2.5% | 0.4% |
| Fracturea broken bone | 5 | 2.1% | 0.4% |
| Gas/air leak | 5 | 2.1% | 0.4% |
| Decrease in pressure | 4 | 1.7% | 0.4% |
| Component missing | 3 | 1.3% | 0.3% |
| Crackthe device cracked | 3 | 1.3% | 0.4% |
| Failure to infuse | 3 | 1.3% | 0.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 20 | 8.3% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 12 | 5% |
| Exposure to body fluids | 11 | 4.6% |
| Perforation | 3 | 1.3% |
| Foreign body in patientpart of a device left in the patient | 2 | 0.8% |
| Hematuria | 1 | 0.4% |
| Injurya physical injury | 1 | 0.4% |
| Laceration(s) | 1 | 0.4% |
| Painpain, site not specified | 1 | 0.4% |
| Peritonitis | 1 | 0.4% |
| Tissue damage | 1 | 0.4% |
| Urinary tract infectionbladder or urinary infection | 1 | 0.4% |
| Vomitingbeing sick | 1 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Bard X-Force Balloon Dilation Catheter | Product code EZN | All MAUDE reports |
|---|---|---|---|
| Reports | 240 | 1,112 | 26,136,888 |
| Share of that pool | — | 21.6% | 0% |
| Classified as death, per 1,000 reports | 0 | 5 | 9 |
| Classified as injury | 7.5% | 24.6% | 36.2% |
| Classified as malfunction | 92.5% | 73.6% | 62.3% |
| Filed by the manufacturer | 99.6% | 93.2% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code EZN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| UroMax Ultra | 158 | 9 | 0% |
| Percuflex Plus | 458 | 50 | 0.4% |
| Rusch | 285 | 0 | 1.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Bard X-Force Balloon Dilation Catheter reports
How many FDA reports name Bard X-Force Balloon Dilation Catheter?
240 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 22 in the latest 12 months.
What kinds of events are reported?
malfunction (92.5%) and injury (7.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
fluid/blood leak (25%), inflation problem (15.4%), burst container or vessel (13.3%), material fragmentation (12.1%) and material rupture (9.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Bard X-Force Balloon Dilation Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.